BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36928374)

  • 1. A matched case-control study in Taiwan to evaluate potential risk factors for prostate cancer.
    Chang HJ; Pong YH; Chiang CY; Huang PC; Wang MH; Chan YJ; Lan TY
    Sci Rep; 2023 Mar; 13(1):4382. PubMed ID: 36928374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A non-socially-sensitive predictive model of prostate cancer for Asian males with benign prostatic hyperplasia: A multi-site cross-sectional case-control study.
    Chang HJ; Moi SH; Chan YJ; Lan TY
    PLoS One; 2023; 18(12):e0295608. PubMed ID: 38079423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
    Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
    World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.
    Liang JA; Sun LM; Lin MC; Chang SN; Sung FC; Muo CH; Kao CH
    Oncologist; 2012; 17(7):986-91. PubMed ID: 22723508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Herpes viruses and human papillomavirus in prostate cancer: first results].
    Mikhaleva L M; Kamalov A A; Karpov V K; Okhobotov D A; Akopyan E P; Shakhpazyan N K; Shaparov B M; Nesterova O Y; Martirosyan L K; Ekhoyan M M; Osmanov O A
    Urologiia; 2023 Dec; (6):95-101. PubMed ID: 38156690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etiologic correlations of prostate cancer in Guangdong, China to family history of cancers, and sexual and marital factors-a case-control study].
    Liang CH; Liu Q; Zhou FJ; Gao X; Chen LW
    Ai Zheng; 2007 May; 26(5):484-8. PubMed ID: 17672937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study.
    Hrbacek J; Urban M; Hamsikova E; Tachezy R; Eis V; Brabec M; Heracek J
    BMC Cancer; 2011 Feb; 11():53. PubMed ID: 21291519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and body composition in prostate cancer and benign prostatic hyperplasia patients.
    Cimino S; Favilla V; Russo GI; Galvano F; Li Volti G; Barbagallo I; Giofrè SV; D'Orazio N; DI Rosa A; Madonia M; Morgia G
    Anticancer Res; 2014 Sep; 34(9):5051-6. PubMed ID: 25202090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum concentrations of folate vitamers in patients with a newly diagnosed prostate cancer or hyperplasia.
    Awwad HM; Ohlmann CH; Stoeckle M; Geisel J; Obeid R
    Clin Biochem; 2018 Jun; 56():41-46. PubMed ID: 29673813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer.
    Aydin M; Bozkurt A; Cikman A; Gulhan B; Karabakan M; Gokce A; Alper M; Kara M
    Int Braz J Urol; 2017; 43(1):36-46. PubMed ID: 28124524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental and psycho-social factors related to prostate cancer risk in the Chinese population: a case-control study.
    Li ML; Lin J; Hou JG; Xu L; Cui XG; Xu XX; Yu YW; Han X; Wang GM; Guo JM; Xu DF; Thompson TC; Cao GW; Zhang HW
    Biomed Environ Sci; 2014 Sep; 27(9):707-17. PubMed ID: 25256860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of high-risk HPV 16/18 infections with prostate cancer].
    Huang L; Wu MG; He J; Wei ZS; Lü WX; Song XJ; Zhang Y; Wu SX; Yin YL; Fan YY
    Zhonghua Nan Ke Xue; 2016 Jun; 22(6):501-505. PubMed ID: 28963837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population.
    Al Shareef Z; Al-Shahrabi R; Saheb Sharif-Askari F; AlDhmanie A; Alshamsi Y; Zarooni AA; Mahmoud RA; Soliman SSM; Halwani R; Bendardaf R
    Prostate; 2024 Feb; 84(2):185-192. PubMed ID: 37969038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the CANARI study: a case-control study investigating the association between prostate cancer and 5-alpha-reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific region in France.
    Scailteux LM; Balusson F; Vincendeau S; Rioux-Leclercq N; Nowak E
    Fundam Clin Pharmacol; 2018 Feb; 32(1):120-129. PubMed ID: 28856711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.
    Takahashi H; Lu W; Watanabe M; Katoh T; Furusato M; Tsukino H; Nakao H; Sudo A; Suzuki H; Akakura K; Ikemoto I; Asano K; Ito T; Wakui S; Muto T; Hano H
    Int J Cancer; 2003 Nov; 107(2):224-8. PubMed ID: 12949798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study.
    Li WM; Pasaribu N; Lee SS; Tsai WC; Li CY; Lin GT; Chuang HY; Tung YC; Tu HP
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):277-286. PubMed ID: 29858589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer.
    Montie JE; Pienta KJ
    Urology; 1994 Jun; 43(6):892-9. PubMed ID: 7515207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.